Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice

Biochemical Pharmacology

Volumn 84, Issue 6, 2012, Pages 821-829

  Li, Zhaosha ^a   Wang, Yanan ^b   Van Der Sluis, Ronald J ^a   Van Der Hoorn, José W A ^c   Princen, Hans M G ^c   Van Eck, Miranda ^a   Van Berkel, Theo J C ^a   Rensen, Patrick C N ^b   Hoekstra, Menno ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TNO   (Netherlands)

Author keywords

CETP; Lipoprotein; Liver; Macrophages; Niacin

Indexed keywords

ABC TRANSPORTER G1; CD68 ANTIGEN; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; NICOTINIC ACID; RNA;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENIC DIET; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEPATITIS; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ISOLATION;

ADIPOSE TISSUE, WHITE; ANIMALS; APOLIPOPROTEIN E3; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; LIVER; MACROPHAGES; MICE; MICE, TRANSGENIC; NIACIN; ORPHAN NUCLEAR RECEPTORS;

EID: 84864952831     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.06.020     Document Type: Article

References (51)

1. L.A. Carlson Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review J Intern Med 258 2005 94 114
2. S.M. Grundy, H.Y. Mok, L. Zech, and M. Berman Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man J Lipid Res 22 1981 24 36
3. L.A. Carlson Niaspan, the prolonged release preparation of nicotinic acid (niacin), the broad-spectrum lipid drug Int J Clin Pract 58 2004 706 713
4. J.M. Lee, M.D. Robson, L.M. Yu, C.C. Shirodaria, C. Cunnington, and I. Kylintireas Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study J Am Coll Cardiol 54 2009 1787 1794
5. A.J. Taylor, T.C. Villines, E.J. Stanek, P.J. Devine, L. Griffen, and M. Miller Extended-release niacin or ezetimibe and carotid intima-media thickness N Engl J Med 361 2009 2113 2122
6. J.W. van der Hoorn, W. de Haan, J.F. Berbée, L.M. Havekes, J.W. Jukema, and P.C. Rensen Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice Arterioscler Thromb Vasc Biol 28 2008 2016 2022
7. P.J. Barter, H.B. Brewer Jr., M.J. Chapman, C.H. Hennekens, D.J. Rader, and A.R. Tall Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis Arterioscler Thromb Vasc Biol 23 2003 160 167
8. M. Westerterp, C.C. van der Hoogt, W. de Haan, E.H. Offerman, G.M. Dallinga-Thie, and J.W. Jukema Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice Arterioscler Thromb Vasc Biol 26 2006 2552 2559
9. E. Wisse An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids J Ultrastruct Res 31 1970 125 150
10. E. Nemeth, A.W. Baird, and C. O'Farrelly Microanatomy of the liver immune system Semin Immunopathol 31 2009 333 343
11. L. Bouwens, D. Knook, and E. Wisse Local proliferation and extrahepatic recruitment of liver macrophages (Kupffer cells) in partial-body irradiated rats J Leukoc Biol 39 1986 687 697
12. M. van Eck, D. Ye, R.B. Hildebrand, J.K. Kruijt, W. de Haan, and M. Hoekstra Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice Circ Res 100 2007 678 685
13. M.E. Pape, R.G. Ulrich, T.J. Rea, K.R. Marotti, and G.W. Melchior Evidence that the nonparenchymal cells of the liver are the principal source of cholesteryl ester transfer protein in primates J Biol Chem 266 1991 12829 12831
14. A. Schaub, A. Futterer, and K.P.U.M.A-G. Pfeffer an IFN-gamma-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily Eur J Immunol 31 2001 3714 3725
15. S. Tunaru, J. Kero, A. Schaub, C. Wufka, A. Blaukat, and K. Pfeffer PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect Nat Med 9 2003 352 355
16. B.J. Wu, K. Chen, P.J. Barter, and K.A. Rye Niacin inhibits vascular inflammation via the induction of heme oxygenase-1 Circulation 125 2012 150 158
17. W.Y. Kwon, G.J. Suh, K.S. Kim, and Y.H. Kwak Niacin attenuates lung inflammation and improves survival during sepsis by downregulating the nuclear factor-κB pathway Crit Care Med 39 2011 328 334
18. S.H. Ganji, S. Qin, L. Zhang, V.S. Kamanna, and M.L. Kashyap Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells Atherosclerosis 202 2009 68 75
19. X.C. Jiang, L.B. Agellon, A. Walsh, J.L. Breslow, and A. Tall Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences J Clin Invest 90 1992 1290 1295
20. L. Demetrius Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans EMBO Rep 6 2005 S39 S44
21. A.H. Terpstra Differences between humans and mice in efficacy of the body fat lowering effect of conjugated linoleic acid: role of metabolic rate J Nutr 131 2001 2067 2068
22. J.H. Lin Species similarities and differences in pharmacokinetics Drug Metab Dispos 23 1995 1008 1021
23. Y. Henkin, A. Oberman, D.C. Hurst, and J.P. Segrest Niacin revisited: clinical observations on an important but underutilized drug Am J Med 91 1991 239 246
24. M.A. Ingersoll, S. Potteaux, D. Alvarez, S.B. Hutchison, N. van Rooijen, and G.J. Randolph Niacin inhibits skin dendritic cell mobilization in a GPR109A independent manner but has no impact on monocyte trafficking in atherosclerosis Immunobiology 217 2012 548 557
25. M. Hernandez, S.D. Wright, and T.Q. Cai Critical role of cholesterol ester transfer protein in nicotinic acid-mediated HDL elevation in mice Biochem Biophys Res Commun 355 2007 1075 1080
26. X. Li, J.S. Millar, N. Brownell, F. Briand, and D.J. Rader Modulation of HDL metabolism by the niacin receptor GPR109A in mouse hepatocytes Biochem Pharmacol 80 2010 1450 1457
27. T. Gautier, U.J. Tietge, R. Boverhof, F.G. Perton, N. Le Guern, and D. Masson Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer protein J Lipid Res 48 2007 30 40
28. M.J. Haas, A.R. Alamir, S. Sultan, J.M. Chehade, N.C. Wong, and A.D. Mooradian Nicotinic acid induces apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines Metabolism 60 2011 1790 1796
29. Y. Luo, and A.R. Tall Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element J Clin Invest 105 2000 513 520
30. P. Costet, Y. Luo, N. Wang, and A.R. Tall Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor J Biol Chem 275 2000 28240 28245
31. Z. Benyó, A. Gille, J. Kero, M. Csiky, M.C. Suchá nková, and R.M. Nüsing GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing J Clin Invest 115 2005 3634 3640
32. M. Lukasova, C. Malaval, A. Gille, J. Kero, and S. Offermanns Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells J Clin Invest 121 2011 1163 1173
33. D. Ferenbach, and J. Hughes Macrophages and dendritic cells: what is the difference Kidney Int 74 2008 5 7
34. D. Ye, B. Lammers, Y. Zhao, I. Meurs, T. Van Berkel, and M. Van Eck ATP-binding cassette transporters A1 and G1, HDL metabolism, cholesterol efflux, and inflammation: important targets for the treatment of atherosclerosis Curr Drug Targets 12 2011 647 660
35. R. Out, M. Hoekstra, R.B. Hildebrand, J.K. Kruit, I. Meurs, and Z. Li Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice Arterioscler Thromb Vasc Biol 26 2006 2295 2300
36. J.I. Rader, R.J. Calvert, and J.N. Hathcock Hepatic toxicity of unmodified and time-release preparations of niacin Am J Med 92 1992 77 81
37. G.E. Mullin, J.K. Greenson, and M.C. Mitchell Fulminant hepatic failure after ingestion of sustained-release nicotinic acid Ann Intern Med 111 1989 253 255
38. Y. Li, S. Xu, A. Giles, K. Nakamura, J.W. Lee, and X. Hou Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver FASEB J 25 2011 1664 1679
39. D. Wanders, and R.L. Judd Future of GPR109A agonists in the treatment of dyslipidaemia Diabetes Obes Metab 13 2011 685 691
40. A. Linke, M. Sonnabend, M. Fasshauer, R. Höllriegel, G. Schuler, and J. Niebauer Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance Atherosclerosis 205 2009 207 213
41. V. Racanelli, and B. Rehermann The liver as an immunological organ Hepatology 43 2006 S54 S62
42. P.J. MacPhee, E.E. Schmidt, and A.C. Groom Evidence for Kupffer cell migration along liver sinusoids, from high-resolution in vivo microscopy Am J Physiol 263 1992 G17 G23
43. N. Lanthier, O. Molendi-Coste, Y. Horsmans, N. van Rooijen, P.D. Cani, and I.A. Leclercq Kupffer cell activation is a causal factor for hepatic insulin resistance Am J Physiol Gastrointest Liver Physiol 298 2010 G107 G116
44. K. Wouters, P.J. van Gorp, V. Bieghs, M.J. Gijbels, H. Duimel, and D. Lütjohann Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis Hepatology 48 2008 474 486
45. J.W. Park, G. Jeong, S.J. Kim, M.K. Kim, and S.M. Park Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients J Gastroenterol Hepatol 22 2007 491 497
46. F. Tacke, T. Luedde, and C. Trautwein Inflammatory pathways in liver homeostasis and liver injury Clin Rev Allergy Immunol 36 2009 4 12
47. E. Kunisch, R. Fuhrmann, A. Roth, R. Winter, W. Lungershausen, and R.W. Kinne Macrophage specificity of three anti-CD68 monoclonal antibodies (KP1, EBM11, and PGM1) widely used for immunohistochemistry and flow cytometry Ann Rheum Dis 63 2004 774 784
48. K. Micklem, E. Rigney, J. Cordell, D. Simmons, P. Stross, and H. Turley A human macrophage-associated antigen (CD68) detected by six different monoclonal antibodies Br J Haematol 73 1989 6 11
49. W. Huang, A. Metlakunta, N. Dedousis, P. Zhang, I. Sipula, and J.J. Dube Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance Diabetes 59 2010 347 357
50. M. Hoekstra, J.K. Kruijt, M. Van Eck, and T.J. Van Berkel Specific gene expression of ATP-binding cassette transporters and nuclear hormone receptors in rat liver parenchymal, endothelial, and Kupffer cells J Biol Chem 278 2003 25448 25453
51. D. Ye, M. Hoekstra, R. Out, I. Meurs, J.K. Kruijt, and R.B. Hildebrand Hepatic cell-specific ATP-binding cassette (ABC) transporter profiling identifies putative novel candidates for lipid homeostasis in mice Atherosclerosis 196 2008 650 658